Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

<p><strong>BACKGROUND:</strong><em>Plasmodium vivax</em> malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for <em>P. vivax</em>, has been reported in the country and has potential to undermine...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Htun, M, Mon, N, Aye, K, Hlaing, C, Kyaw, M, Handayuni, I, Trimarsanto, H, Bustos, D, Ringwald, P, Price, R, Auburn, S, Thriemer, K
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	BioMed Central 2017

Míreanna comhchosúla

Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan
de réir: Wangchuk, S, et al.
Foilsithe / Cruthaithe: (2016)

Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
de réir: Getachew, S, et al.
Foilsithe / Cruthaithe: (2015)

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
de réir: Guthmann, J, et al.
Foilsithe / Cruthaithe: (2008)

Plasmodium vivax trophozoites insensitive to chloroquine.
de réir: Sharrock, W, et al.
Foilsithe / Cruthaithe: (2008)

Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
de réir: Yuan, L, et al.
Foilsithe / Cruthaithe: (2014)

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
de réir: Wirjanata, G, et al.
Foilsithe / Cruthaithe: (2015)

<it>Plasmodium vivax </it>trophozoites insensitive to chloroquine
de réir: Jaidee Anchalee, et al.
Foilsithe / Cruthaithe: (2008-05-01)

Chloroquine resistance in Plasmodium vivax.
de réir: Baird, J
Foilsithe / Cruthaithe: (2004)

Chloroquine sensitivity of Plasmodium vivax in Thailand.
de réir: Looareesuwan, S, et al.
Foilsithe / Cruthaithe: (1999)

Plasmodium falciparum and P. vivax demonstrate contrasting chloroquine resistance reversal phenotypes
de réir: Wirjanata, G, et al.
Foilsithe / Cruthaithe: (2017)

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
de réir: Nateghpour M, et al.
Foilsithe / Cruthaithe: (2007-09-01)

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
de réir: Nateghpour M, et al.
Foilsithe / Cruthaithe: (2007-09-01)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (1995)

Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern Ethiopia.
de réir: Sisay Getachew, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (1996)

Genetic diversity of chloroquine-resistant Plasmodium vivax parasites from the western Brazilian Amazon
de réir: Omaira Vera Lizcano, et al.
Foilsithe / Cruthaithe: (2014-11-01)

Further evidence of increasing diversity of Plasmodium vivax in the Republic of Korea in recent years
de réir: Kim, J, et al.
Foilsithe / Cruthaithe: (2016)

Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2018)

Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2018)

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar
de réir: Kyaw, M, et al.
Foilsithe / Cruthaithe: (2013)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
de réir: Smithuis, F, et al.
Foilsithe / Cruthaithe: (1997)

Genetic diversity and population structure of Plasmodium vivax in Central China.
de réir: Liu, Y, et al.
Foilsithe / Cruthaithe: (2014)

Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: An open-label, randomized, controlled trial.
de réir: Grigg, M, et al.
Foilsithe / Cruthaithe: (2016)

In vivo Susceptibility of Plasmodium vivax to Chloroquine in Southeastern Iran.
de réir: Heidari, A, et al.
Foilsithe / Cruthaithe: (2012)

Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (1991)

Chloroquine-resistant Plasmodium vivax in Pakistan: an emerging threat
de réir: Ammara Khan, et al.
Foilsithe / Cruthaithe: (2016-11-01)

In Vivo Susceptibility of Plasmodium Vivax to Chloroquine in Southeastern Iran
de réir: S Dittrich, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
de réir: Price, R, et al.
Foilsithe / Cruthaithe: (2005)

New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
de réir: Price, R, et al.
Foilsithe / Cruthaithe: (2009)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
de réir: Suwanarusk, R, et al.
Foilsithe / Cruthaithe: (2007)

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
de réir: Abreha, T, et al.
Foilsithe / Cruthaithe: (2017)

Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.
de réir: Baird, J, et al.
Foilsithe / Cruthaithe: (1997)

Genetic diversity of Plasmodium vivax and Plasmodium falciparum lactate dehydrogenases in Myanmar isolates
de réir: Jinyoung Lee, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
de réir: Thu Zar Han, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
de réir: Rossarin Suwanarusk, et al.
Foilsithe / Cruthaithe: (2007-10-01)

Monitoring of clinical efficacy and <it>in vitro </it>sensitivity of <it>Plasmodium vivax </it>to chloroquine in area along Thai Myanmar border during 2009-2010
de réir: Rungsihirunrat Kanchana, et al.
Foilsithe / Cruthaithe: (2011-02-01)

Plasmodium vivax in the era of the shrinking P. falciparum map
de réir: Price, RN, et al.
Foilsithe / Cruthaithe: (2020)

Emerging Plasmodium vivax resistance to chloroquine in South America: an overview
de réir: Lígia Antunes Gonçalves, et al.
Foilsithe / Cruthaithe: (2014-08-01)

Chloroquine-resistant <it>Plasmodium vivax </it>malaria in Debre Zeit, Ethiopia
de réir: Muchohi Simon, et al.
Foilsithe / Cruthaithe: (2008-10-01)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials.
de réir: Commons, R, et al.
Foilsithe / Cruthaithe: (2017)